Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-05

Clinical Trial Update: Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cyclophosphamide, antithymocyte globulin, and total-body irradiation as part of umbilical cord blood transplantation for severe aplasti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antithymocyte Globulin (anti-thymocyte globulin)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Aplastic Anemia | Phase 1 | Status: TERMINATED